Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Thomson

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|October 12, 2022
The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: A randomized first-in-human studyKate Thomson, Cindy Karouta, Faran Sabeti, et al.
BMC Medical Education|June 12, 2024
An integrative review of the impact of allied health student placements on current staff's knowledge and procedural skills in acute and primary care settingsMohammad Hamiduzzaman, Sarah Miles, Sarah Crook, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2015
Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgEAnne-Kathrin Kienzler, Pauline A van Schouwenburg, John Taylor, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 12, 2021
Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance studyBetty Raman, Robert W Smillie, Masliza Mahmod, et al.
Frontiers in Psychiatry|February 8, 2024
Adapting the ADVANCE group program for digitally-supported delivery to reduce intimate partner violence by men in substance use treatment: a feasibility studyGail Gilchrist, Sandi Dheensa, Amy Johnson, et al.
Pilot and Feasibility Studies|July 30, 2022
The feasibility of delivering the ADVANCE digital intervention to reduce intimate partner abuse by men receiving substance use treatment: protocol for a non-randomised multi-centre feasibility study and embedded process evaluationGail Gilchrist, Sabine Landau, Sandi Dheensa, et al.
Scientific Reports|March 25, 2025
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamtenLisa Leinhos, Paul Robinson, Giulia Poloni, et al.
Investigative Ophthalmology & Visual Science|December 2, 2025
IMI: The Role of Light in Refractive Development and Myopia: Evidence from Animal and Human StudiesRegan Ashby, Elise N Harb, Lisa A Ostrin, et al.
Circulation. Genomic and Precision Medicine|January 26, 2019
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy GenesJodie Ingles, Jennifer Goldstein, Courtney Thaxton, et al.
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|October 12, 2022
The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: A randomized first-in-human studyKate Thomson, Cindy Karouta, Faran Sabeti, et al.
BMC Medical Education|June 12, 2024
An integrative review of the impact of allied health student placements on current staff's knowledge and procedural skills in acute and primary care settingsMohammad Hamiduzzaman, Sarah Miles, Sarah Crook, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2015
Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgEAnne-Kathrin Kienzler, Pauline A van Schouwenburg, John Taylor, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 12, 2021
Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance studyBetty Raman, Robert W Smillie, Masliza Mahmod, et al.
Frontiers in Psychiatry|February 8, 2024
Adapting the ADVANCE group program for digitally-supported delivery to reduce intimate partner violence by men in substance use treatment: a feasibility studyGail Gilchrist, Sandi Dheensa, Amy Johnson, et al.
Pilot and Feasibility Studies|July 30, 2022
The feasibility of delivering the ADVANCE digital intervention to reduce intimate partner abuse by men receiving substance use treatment: protocol for a non-randomised multi-centre feasibility study and embedded process evaluationGail Gilchrist, Sabine Landau, Sandi Dheensa, et al.
Scientific Reports|March 25, 2025
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamtenLisa Leinhos, Paul Robinson, Giulia Poloni, et al.
Investigative Ophthalmology & Visual Science|December 2, 2025
IMI: The Role of Light in Refractive Development and Myopia: Evidence from Animal and Human StudiesRegan Ashby, Elise N Harb, Lisa A Ostrin, et al.
Circulation. Genomic and Precision Medicine|January 26, 2019
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy GenesJodie Ingles, Jennifer Goldstein, Courtney Thaxton, et al.
American Journal of Human Genetics|August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findingsKathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
Pageof 5